Key Takeaways Eli Lilly and Novo Nordisk shares rose Tuesday after the Biden administration proposed expanding coverage of the companies’…
Read More »Nordisk
Key Takeaways Novo Nordisk’s U.S.-listed shares rose Wednesday morning as third-quarter profits beat estimates and sales of Ozempic and Wegovy…
Read More »Key Takeaways Hims’ third-quarter results topped expectations, driven in part by revenue from its weight-loss drugs. The company said it…
Read More »Key Takeaways Novo Nordisk CEO Lars Fruergaard Jorgensen will testify Tuesday before a Senate panel looking into the drug maker’s…
Read More »Key Takeaways Novo Nordisk’s U.S.-listed shares lost ground Friday after a Phase 2a trial of the pharmaceutical firm’s latest obesity…
Read More »<img src='https://www.investopedia.com/thmb/AIq_avuLkl5zDDidl7t0N1Y3JP0=/filters:no_upscale():max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1690265028-388edef8c47f4184bfba3e5deda32f0c.jpg' alt=' Christian Schultz / picture alliance / Getty Images ‘ title=”Novo Nordisk logo on office building”> Christian Schultz…
Read More »Key Takeaways American depositary receipts (ADRs) of Novo Nordisk rose in intraday trading Friday after an Oxford study showed the…
Read More »Key Takeaways Novo Nordisk and Eli Lilly shares lost ground Tuesday after U.S. President Joe Biden and Senator Bernie Sanders…
Read More »Key Takeaways American depositary receipts (ADRs) of Danish drugmaker Novo Nordisk rose Tuesday after the company announced that its popular…
Read More »